company background image
MAYBAKER

May & Baker Nigeria NGSE:MAYBAKER Stock Report

Last Price

₦3.76

Market Cap

₦6.5b

7D

-0.3%

1Y

-16.3%

Updated

27 Nov, 2022

Data

Company Financials
MAYBAKER fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health2/6
Dividends2/6

MAYBAKER Stock Overview

May & Baker Nigeria Plc manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

May & Baker Nigeria plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for May & Baker Nigeria
Historical stock prices
Current Share Price₦3.76
52 Week High₦5.45
52 Week Low₦3.35
Beta0.14
1 Month Change-4.08%
3 Month Change-3.09%
1 Year Change-16.26%
3 Year Change83.41%
5 Year Change38.75%
Change since IPO180.75%

Recent News & Updates

Recent updates

Shareholder Returns

MAYBAKERNG PharmaceuticalsNG Market
7D-0.3%4.6%5.4%
1Y-16.3%15.8%-1.2%

Return vs Industry: MAYBAKER underperformed the NG Pharmaceuticals industry which returned 15.8% over the past year.

Return vs Market: MAYBAKER underperformed the NG Market which returned -1.2% over the past year.

Price Volatility

Is MAYBAKER's price volatile compared to industry and market?
MAYBAKER volatility
MAYBAKER Average Weekly Movement6.4%
Pharmaceuticals Industry Average Movement4.3%
Market Average Movement5.5%
10% most volatile stocks in NG Market6.9%
10% least volatile stocks in NG Market2.8%

Stable Share Price: MAYBAKER is more volatile than 75% of NG stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: MAYBAKER's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of NG stocks.

About the Company

FoundedEmployeesCEOWebsite
1944357Patrick Ajahhttps://www.may-baker.com

May & Baker Nigeria Plc manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic; anti-hypersensitive; anti-infective; anti-malaria; analgesic; cough and cold; anxiolytics; and nature care products.

May & Baker Nigeria plc Fundamentals Summary

How do May & Baker Nigeria's earnings and revenue compare to its market cap?
MAYBAKER fundamental statistics
Market Cap₦6.49b
Earnings (TTM)₦1.60b
Revenue (TTM)₦14.18b

4.1x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MAYBAKER income statement (TTM)
Revenue₦14.18b
Cost of Revenue₦10.51b
Gross Profit₦3.68b
Other Expenses₦2.08b
Earnings₦1.60b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.93
Gross Margin25.92%
Net Profit Margin11.26%
Debt/Equity Ratio90.8%

How did MAYBAKER perform over the long term?

See historical performance and comparison

Dividends

8.0%

Current Dividend Yield

32%

Payout Ratio